Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Steven Ivulich"'
Publikováno v:
Transplant International. 36
Everolimus (EVE) provides an alternative to maintenance immunosuppression when conventional immunosuppression cannot be tolerated. EVE can be utilized with a calcineurin inhibitor (CNI) minimization or elimination strategy. To date, clinical studies
Publikováno v:
J Thorac Dis
Lung transplantation (LTx) has evolved significantly since its inception and the improvement in LTx outcomes over the last three decades has predominantly been driven by advances in immunosuppression management. Despite the lack of new classes of imm
Autor:
Katrina Ford, Lisa Peters, Kyle L. Dawson, Tara Miller, A. Cochrane, Reda E. Girgis, Linda J. Stuckey, H. Lyster, Doug Jennings, Michelle M. Kittleson, Phillip Weeks, Stuart D. Russell, T. Tse, Janet Scheel, Maureen Flattery, Monica Colvin, Christina T. Doligalski, Robert L. Page, M. Shullo, Steven Ivulich, Tamara Claridge, Martin Schweiger, C. Yost, Kathleen E. Simpson, JoAnn Lindenfeld, T. Khuu, Christopher R. Ensor, David Weill, Anne I. Dipchand, David A. Baran, Patricia A. Uber
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:1050-1069
In 2009, the International Society for Heart and Lung Transplantation recognized the importance and challenges surrounding generic drug immunosuppression. As experience with generics has expanded and comfort has increased, substantial issues have ari
Autor:
Nobenguni Ndiweni, Jaideep Vazirani, R. Martin, Kirstie Wilson, Jodi Gillot, Jane Harris, Daniela Burke, Greg Snell, Kovi Levin, Emily Yates, Steven Ivulich, Belinda Bourne, Bronwyn Levvey, Jane Miller, Hilary Stedman, G.P. Westall
Publikováno v:
Transplant Journal of Australasia. 30
Publikováno v:
Journal of pharmacy practice. 35(1)
Posaconazole is widely used in lung transplant recipients as pre-emptive therapy or universal fungal prophylaxis. In this patient group, posaconazole is increasingly used instead of voriconazole due to the concerns of an increased risk of squamous ce
Autor:
Steven Ivulich, Gregory I Snell
Publikováno v:
Australian journal of general practice. 49(3)
BACKGROUND General practitioners are increasingly likely to encounter elderly patients who are receiving immunosuppressants for the management of autoimmune diseases or solid organ transplants. OBJECTIVE The aim of this article is to provide an overv
Publikováno v:
Drugs. 78:965-982
Advances in immunosuppression have been a key component to the ongoing success of lung transplantation. The demographics of patients receiving a lung transplant have evolved with older, more critically ill patients and those with previously contraind
Autor:
Monica A. Slavin, C. Orla Morrissey, Chin Fen Neoh, Steven Ivulich, David C. M. Kong, Glen P. Westall, Bronwyn Levvey, Wirawan Jeong, Rory Wolfe, Gregory I Snell
Publikováno v:
Journal of Antimicrobial Chemotherapy. 73:748-756
Objectives: This study describes therapeutic drug monitoring (TDM) of posaconazole suspension and modified release (MR) tablets in lung transplant (LTx) recipients and evaluates factors that may affect posaconazole trough plasma concentration (Cmin).
Publikováno v:
Transplantation Proceedings. 49:2153-2160
Lung transplantation (LTx) is a successful treatment option for end-stage lung disease, and immunosuppressant regimens, utilized to prevent rejection of the transplanted graft, are paramount to maintaining long-term graft survival. Immunosuppression
Autor:
Monica A. Slavin, Greg Snell, David C. M. Kong, Bronwyn Levvey, Glen P. Westall, Steven Ivulich, Wirawan Jeong, Chin Fen Neoh, C. Orla Morrissey
Publikováno v:
Journal of Antimicrobial Chemotherapy. 72:2089-2092
Objectives This study describes the clinical outcomes and therapeutic drug monitoring (TDM) following posaconazole suspension pre-emptive therapy in lung transplant (LTx) recipients. Methods This was a single-centre, retrospective cohort study evalua